BSE filing, NSE: PRIVISCL. Summary written from the filing by ALFA Finder's alert engine.
Privi Speciality Chemicals Ltd: key numbers
- Share price
- ₹3,500.00
- Market cap
- ₹13,672 Cr
- Revenue (annual)
- ₹2,564 Cr
- Net profit (annual)
- ₹327.5 Cr
- P/E (TTM)
- 39.1×Sector 34.1×
- Promoter holding
- 60.60%+0.00% QoQ
- FII holding
- 2.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Privi Speciality Chemicals Ltd
All →Privi Speciality Chemicals Dividend
Privi Speciality Chemicals declared an interim dividend of Rs 5 per equity share for FY 2026-27 at its 29 October 2026 board meeting. Record date is 04 November 2026 and payment by 25 November 2026.
Privi Speciality Chemicals Q2 FY27 Results: Net Profit ₹117.5 Cr, Up 30.3% YoY
Privi Speciality Chemicals Ltd reported revenue from operations of ₹760.5 Cr (+12.1% YoY) and net profit of ₹117.5 Cr (+30.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹117.5 Cr · +30.3% YoY
Privi Speciality Chemicals Acquisition
Privi Speciality Chemicals' NCLT-convened equity shareholder meeting approved the Scheme of Amalgamation of Privi Fine Sciences and Privi Biotechnologies into the company. The special resolution passed with requisite majority, subject to scrutinizer report.
Privi Speciality Chemicals Board Meeting Date
Privi Speciality Chemicals intimated its board meeting is scheduled for October 29, 2026, to consider Q1/H1 results and an interim dividend. Items are proposed only and not yet decided.
Privi Speciality Chemicals Other Announcement
Privi Speciality Chemicals Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Privi Speciality Chemicals Acquisition
Privi Speciality Chemicals filed NCLT notice for an Oct 27, 2026 shareholders meeting on the amalgamation of Privi Fine Sciences and Privi Biotechnologies into it. No merger consideration value is stated.
Other capital structure change announcements
All →Crescentis Capital Capital Structure Change
Crescentis Capital approved Rights Issue terms: 1,02,08,129 shares at ₹78, raising ₹79.62 Crore. Record date November 4; issue closes November 27, 2026.
- Value
- ₹79.62 Cr
Atul Capital Structure Change
Atul Limited announced an open market buyback of equity shares worth ₹200 Crore. Shares will be purchased via stock exchanges subject to regulatory compliance.
- Value
- ₹200.0 Cr
Bajaj Electricals Capital Structure Change
HDFC Mutual Fund schemes cut their Bajaj Electricals stake by 2.01% to 7.25% as of October 26, 2026. They sold 23,25,060 shares in the open market.
Emkay Global Financial Services Capital Structure Change
Emkay Global will invest ₹30.00 Crore in cash in wholly owned subsidiary Emkay Capital. The related-party deal completes within 90 days.
- Value
- ₹30.00 Cr
- Execution
- Within 90 days
OnEMI Technology Solutions Capital Structure Change
OnEMI will invest ₹624.15 Crore in its wholly owned subsidiary Si Creva via rights subscription. Funds come from preferential issue proceeds, completing by December 2026.
- Value
- ₹624.1 Cr
- Execution
- By end of December 2026
Meesho Capital Structure Change
Meesho approved up to Rs.400 Crore capital infusion into its wholly owned subsidiary, Meesho Payments. Board also approved a new subsidiary and further Kirana Club investments.
- Value
- ₹400.0 Cr